CRIPTO and metastatic neoplasm: Overall, Cripto is commonly associated with advanced or metastatic disease, while the lack of molecular targets or targeted therapies highlights the possibility of Cripto as a pan-cancer prediction biomarker or therapeutic target in combination with treatment schemes.